The Traderszone Network

Genomic Health (NASDAQ: GHDX) closed up 10.2% Tuesday following its announcement of solid fourth-quarter earnings after the bell Monday. The company’s 2017 guidance certainly didn’t hurt investors’ confidence either.

Image source: Getty Images.

Genomic Health delivered 8% more genetic tests in the fourth quarter than it did in Q4 2015. More importantly, product revenue rose even faster — up 10% year over year — as the company was able to get paid for more of its genetic cancer tests from insurers and government programs.

read more

I recently bought shares of seven different companies. One of those companies was AbbVie (NYSE: ABBV). I had different reasons for buying each of the stocks. Some were in sectors in which I didn’t already have much exposure in my portfolio. That wasn’t the case with AbbVie, though. I already owned quite a few healthcare stocks and exchange-traded funds (ETFs).

read more

Charter is slated to report Q4 earnings, but investors will want to hear more about Verizon.

World stocks rose to a whisker off all-time highs on Wednesday and the dollar rose for the 11th straight day following Federal Reserve Chair Janet Yellen’s flagging of a possible interest rate rise next month.

The stock market continued to climb sharply on Wednesday, sending major market benchmarks to record highs yet again and propelling the Dow Jones Industrials up more than 100 points. Economic data continued to support the notion that the U.S. economy remains strong, and rising inflation levels led many to conclude that the Federal Reserve is more likely than ever to follow through on its promise to keep lifting short-term interest rates in 2017.

read more

Just five months ago, fellow Fool Leo Sun compared the investing theses for Intel (NASDAQ: INTC) and NXP Semiconductors (NASDAQ: NXPI). He found NXP to be the better pick, thanks to massive growth opportunities and a low PEG ratio.

read more

Japanese Prime Minister Shinzo Abe said on Wednesday U.S. President Donald Trump shared his view at last week’s summit that Japan’s monetary policy was not currency manipulation but was intended to end deflation.